Science Explorer Interactive view Map
Company · Radnor · United States

Zynerba Pharmaceuticals (United States)

zynerba.comROR OpenAlex
Research works
9
▲ 6764% vs 2013–17
Citations
192
20.7 per fractional work
Top-10% rate
13.4%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Zynerba Pharmaceuticals (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Which research topics does Zynerba Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Genetics and Neurodevelopmental Disorders, Pancreatic function and diabetes, Cannabis and Cannabinoid Research and Attention Deficit Hyperactivity Disorder.

Genetics and Neurodevelo…1Genetics and Neurodevelopmental Disorders: 1 fractional worksPancreatic function and diabetes: 0 fractional worksCannabis and Cannabinoid Research: 0 fractional worksAttention Deficit Hyperactivity Disorder: 0 fractional worksAutism Spectrum Disorder Research: 0 fractional works
GeneticsSurgeryPharmacologyPsychiatry and Mental health1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Genetics and Neurodevelopmental Disorders Genetics 1 works
  2. 2 Pancreatic function and diabetes Surgery 0 works
  3. 3 Cannabis and Cannabinoid Research Pharmacology 0 works
  4. 4 Attention Deficit Hyperactivity Disorder Psychiatry and Mental health 0 works
  5. 5 Autism Spectrum Disorder Research Cognitive Neuroscience 0 works
  6. 6 Epilepsy research and treatment Psychiatry and Mental health 0 works
  7. 7 Vagus Nerve Stimulation Research Neurology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.6%not open57.4%

World: 28% of research is openly available.

with international co-authors30.8%domestic only69.2%

World: 19% is written across borders.

How has Zynerba Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 6764% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Radnor

All research institutions in Radnor

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.